Estrace

— THERAPEUTIC CATEGORIES —
  • Breast cancer
  • Menopause and HRT
  • Prostate and other male cancers

Estrace Generic Name & Formulations

General Description

Estradiol 0.5mg, 1mg, 2mg+; scored tabs; +contains tartrazine.

Pharmacological Class

Estrogen.

How Supplied

Tabs—100

Manufacturer

Generic Availability

YES

Estrace Indications

Indications

Palliative treatment of metastatic breast cancer in select patients (see full labeling).

Estrace Dosage and Administration

Adult

10mg 3 times daily for at least 3 months.

Children

Not applicable.

Estrace Contraindications

Contraindications

Thrombophlebitis. Thromboembolic disorders. Cerebrovascular disorders. Abnormal undiagnosed genital bleeding. Estrogen-depended neoplasias. Liver dysfunction or disease. Pregnancy (Cat. X).

Estrace Boxed Warnings

Boxed Warning

Endometrial cancer. Breast cancer. Cardiovascular disorders. Probable dementia.

Estrace Warnings/Precautions

Warnings/Precautions

Asthma (2mg tabs). Hepatic dysfunction. Conditions aggravated by fluid retention. Cardiovascular disorders, arterial vascular disease, and risks factors (eg, hypertension, diabetes, obesity, SLE). Familial hyperlipoprotenemia. Monitor BP. Discontinue if jaundice occurs and before prolonged immobilization (eg, surgery). Nursing mothers.

Estrace Pharmacokinetics

See Literature

Estrace Interactions

Not Applicable

Estrace Adverse Reactions

Adverse Reactions

See full labeling. GI upset, headache, hypertension, edema, hypercalcemia, gallbladder or thromboembolic disease, gynecomastia, impotence, impaired glucose tolerance.

Estrace Clinical Trials

See Literature

Estrace Note

Not Applicable

Estrace Patient Counseling

See Literature

Estrace Generic Name & Formulations

General Description

Estradiol 0.5mg, 1mg, 2mg+; scored tabs; +contains tartrazine.

Pharmacological Class

Estrogen.

How Supplied

Tabs—100

Manufacturer

Generic Availability

YES

Estrace Indications

Indications

Moderate-to-severe vasomotor symptoms of menopause. Atrophic vaginitis. Hypoestrogenism. Osteoporosis prevention.

Estrace Dosage and Administration

Adult

Menopause, hypoestrogenism: 1–2mg daily, given cyclically (3 weeks on, 1 week off). Osteoporosis prevention (begin therapy soon after menopause): 0.5mg daily for 3 weeks, then stop for 1 week, then recycle; adjust. Reevaluate periodically.

Children

Not applicable.

Estrace Contraindications

Contraindications

Breast or estrogen-dependent cancer. Thrombophlebitis. Thromboembolic disorders. Undiagnosed abnormal genital bleeding. Pregnancy (Cat.X).

Estrace Boxed Warnings

Boxed Warning

Endometrial cancer. Breast cancer. Cardiovascular disorders. Probable dementia.

Estrace Warnings/Precautions

Warnings/Precautions

Increased risk of endometrial carcinoma or hyperplasia in women with intact uterus (adding progestin is essential). Increased risk of cardiovascular events (eg, MI, stroke, VTE); discontinue if occurs. Manage risk factors for cardiovascular disease and venous thromboembolism appropriately. Breast cancer. Risk of probable dementia in women >65yrs of age. Asthma (2mg tabs). Hepatic dysfunction. Conditions aggravated by fluid retention. Familial hyperlipoproteinemia. Do initial complete physical examination and repeat annually (include BP, mammogram, and PAP smear). Discontinue if jaundice occurs. Nursing mothers.

Estrace Pharmacokinetics

See Literature

Estrace Interactions

Not Applicable

Estrace Adverse Reactions

Adverse Reactions

See full labeling. Mastodynia, breast secretion, uterine bleeding, dysmenorrhea, amenorrhea, GI upset, headache, hypertension, edema, hypercalcemia, gallbladder or thromboembolic disease, skin changes.

Estrace Clinical Trials

See Literature

Estrace Note

Not Applicable

Estrace Patient Counseling

See Literature

Estrace Generic Name & Formulations

General Description

Estradiol 0.5mg, 1mg, 2mg+; scored tabs; +contains tartrazine.

Pharmacological Class

Estrogen.

How Supplied

Tabs—100

Manufacturer

Generic Availability

YES

Estrace Indications

Indications

Palliative treatment of androgen-dependent advanced prostate cancer.

Estrace Dosage and Administration

Adult

1–2mg 3 times daily.

Children

Not applicable.

Estrace Contraindications

Contraindications

Thrombophlebitis. Thromboembolic disorders. Cerebrovascular disorders. Abnormal undiagnosed genital bleeding. Estrogen-depended neoplasias. Liver dysfunction or disease. Pregnancy (Cat. X).

Estrace Boxed Warnings

Boxed Warning

Endometrial cancer. Breast cancer. Cardiovascular disorders. Probable dementia.

Estrace Warnings/Precautions

Warnings/Precautions

Asthma (2mg tabs). Hepatic dysfunction. Conditions aggravated by fluid retention. Cardiovascular disorders, arterial vascular disease, and risks factors (eg, hypertension, diabetes, obesity, SLE). Familial hyperlipoprotenemia. Monitor BP. Discontinue if jaundice occurs and before prolonged immobilization (eg, surgery). Nursing mothers.

Estrace Pharmacokinetics

See Literature

Estrace Interactions

Not Applicable

Estrace Adverse Reactions

Adverse Reactions

See full labeling. GI upset, headache, hypertension, edema, hypercalcemia, gallbladder or thromboembolic disease, gynecomastia, impotence, impaired glucose tolerance.

Estrace Clinical Trials

See Literature

Estrace Note

Not Applicable

Estrace Patient Counseling

See Literature